Marcela B. Zubillaga
University of Buenos Aires
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marcela B. Zubillaga.
Nutrition Research | 2000
María J. Salgueiro; Marcela B. Zubillaga; Alexis E. Lysionek; María I. Sarabia; Ricardo A. Caro; Tomas De Paoli; Alfredo Hager; Ricardo Weill; José Boccio
Zinc is one of the most important essential tracer metals of human nutrition, and its deficiency is a world nutritional problem. This work compiles past and present information about the role of zinc in human health.
Nutrition | 2002
María J. Salgueiro; Marcela B. Zubillaga; Alexis E. Lysionek; Ricardo A. Caro; Ricardo Weill; José Boccio
This review concerns the importance of zinc in growth, development, and cognitive function in children and the deleterious consequences of its deficiency on childrens health. Possible strategies to overcome zinc deficiency and the results of some supplementation trials are discussed.
Nutrition Research | 2001
Marcela B. Zubillaga; Ricardo Weill; Eric Postaire; Cinthia G. Goldman; Ricardo A. Caro; José Boccio
The use of functional foods (probiotics and prebiotics) has been demonstrated to be effective for the treatment or control of several diseases. Further well designed trials to examine the effects of different probiotic components are required. It is important to establish separate functions and to gain further insight into the underlying mechanisms that include competitive exclusion and modification of colonic microflora. For a very long time Russians have used kefir for the treatment of a wide range of illnesses. This paper attempts to review the use of probiotic and functional foods in different diseases, with a special emphasis on kefir.
Biological Trace Element Research | 2001
María J. Salgueiro; Nancy F. Krebs; Marcela B. Zubillaga; Ricardo Weill; Eric Postaire; Alexis E. Lysionek; Ricardo A. Caro; Tomas De Paoli; Alfredo Hager; José Boccio
Diabetes mellitus is a group of metabolic disorders, the incidence of which varies widely throughout the world. The treatment of diabetes mellitus includes insulin, oral antidiabetic agents, and dietary regimens. Although the emphasis is on macronutrients intakes, there is strong evidence that there is an abnormal metabolism of several micronutrients in diabetic individuals. Zinc is one of the essential micronutrients of which status and metabolism is altered in this condition. This work is a short review about the close relation among zinc, glucose metabolism, and insulin physiology, as well as about the few experimental data about zinc absorption and zinc supplementation in diabetes mellitus patients.
Nutrition Reviews | 2002
María J. Salgueiro; Marcela B. Zubillaga; Alexis E. Lysionek; Ricardo A. Caro; Ricardo Weill; José Boccio
Food fortification is an important strategy to combat iron and zinc deficiency. This review covers the basic concepts of food fortification, as well as its advantages and disadvantages. The main characteristics of the most common zinc and iron compounds used in this procedure are also analyzed.
Biological Trace Element Research | 2000
María J. Salgueiro; Marcela B. Zubillaga; Alexis E. Lysionek; G. Cremaschi; Cinthia G. Goldman; Ricardo A. Caro; T. De Paoli; Alfredo Hager; Ricardo Weill; José Boccio
The essentiality of zinc for humans was first documented by Prasad in the 1960s. The main clinical manifestations associated with zinc deficiency are growth retardation, hypogonadism, diarrhea, and increased susceptibility to infectious diseases. Thus, in the past 25 yr, there was an increased interest of researchers in studying the role of zinc in human immunity. Although mechanistic research has been carried out using animal models, there are several studies in humans with similar results. This work is an attempt to review the information available in this field to understand the important role that zinc plays in the normal development and function of the immune system.
European Journal of Pharmaceutics and Biopharmaceutics | 2017
Maximiliano Cagel; Fiorella Carla Tesan; Ezequiel Bernabeu; María J. Salgueiro; Marcela B. Zubillaga; Marcela A. Moretton; Diego A. Chiappetta
During the past few decades, polymeric micelles have raised special attention as novel nano-sized drug delivery systems for optimizing the treatment and diagnosis of numerous diseases. These nanocarriers exhibit several in vitro and in vivo advantages as well as increased stability and solubility to hydrophobic drugs. An interesting approach for optimizing these properties and overcoming some of their disadvantages is the combination of two or more polymers in order to assemble polymeric mixed micelles. This review article gives an overview on the current state of the art of several mixed micellar formulations as nanocarriers for drugs and imaging probes, evaluating their ongoing status (preclinical or clinical stage), with special emphasis on type of copolymers, physicochemical properties, in vivo progress achieved so far and toxicity profiles. Besides, the present article presents relevant research outcomes about polymeric mixed micelles as better drug delivery systems, when compared to polymeric pristine micelles. The reported data clearly illustrates the promise of these nanovehicles reaching clinical stages in the near future.
Alimentary Pharmacology & Therapeutics | 2004
Jimena Salgueiro; Marcela B. Zubillaga; Cinthia G. Goldman; A. Barrado; M. Martinez Sarrasague; N. Leonardi; José Boccio
Helicobacter pylori causes a chronic gastric infection, which is usually life‐long. Many epidemiological studies have shown that this is probably one of the most common bacterial infections throughout the world involving 30% of the population living in developed countries and up to 80–90% of the population in developing regions. Concomitantly, developing regions also have high prevalence of micronutrient malnutrition. In the last few years, some studies have suggested that H. pylori infection may affect the homeostasis of different micronutrients including iron, vitamin B12, folic acid, α‐tocopherol, vitamin C and β‐carotene. In this article, we discuss the current scientific information of the effect that H. pylori infection may produce on micronutrient malnutrition.
Nutrition | 2000
María J. Salgueiro; Marcela B. Zubillaga; Alexis E. Lysionek; María I. Sarabia; Ricardo A. Caro; Tomas De Paoli; Alfredo Hager; Eduardo Ettlin; Ricardo Weill; José Boccio
Food fortification with a proper zinc compound is an economic and effective strategy to prevent zinc deficiency. BioZn-AAS, a zinc gluconate stabilized with glycine, was compared with zinc sulfate (reference standard), zinc hydroxide, and zinc gluconate, all of them labeled with (65)Zn. This preclinical study was performed on Sprague-Dawley rats of both sexes, and the administered dose was 85 microg/kg of zinc. Bioavailability studies showed that absorption of BioZn-AAS was not statistically different than absorption from other sources in female rats (25.65% +/- 2.20% for BioZn-AAS, 28.24% +/- 4. 60% for ZnSO(4), 24.91% +/- 4.02% for Zn[OH](2), and 25.51% +/- 2. 70% for Zn-gluconate). In the case of the male rats, absorption of BioZn-AAS (27.97% +/- 4.20%) was higher (P<0.05) than that from the other compounds (23.15% +/- 2.90% for ZnSO(4), 22.62% +/- 3.90% for Zn[OH](2), and 22.30% +/- 3.90% for Zn-gluconate). Biodistribution studies demonstrated that the zinc from BioZn-AAS followed the same metabolic pathway as zinc from the other sources. Toxicity studies were performed with 50 female and 50 male rats. The value of oral lethal dose 50 (LD(50)) was 2000 mg/kg for female rats and 1900 mg/kg for male rats. Therefore, we conclude that BioZn-AAS has adequate properties to be considered a proper zinc compound for food fortification or dietary supplementation.
Nutrition Research | 1999
Raúl Uicich; Fernando Pizarro; Carlos Almeida; María L. Díaz; José Boccio; Marcela B. Zubillaga; Esteban Carmuega; Alejandro O'Donnell
Iron deficiency anemia is the most prevalent nutritional deficiency in Argentina, particularly among infants under 2 years old. At this age the most efficient way to prevent it is through the daily intake of bioavailable iron in weaning foods. Fluid cows milk is the most popular weaning food in our country. Nowadays, it is possible to fortify this kind of food with 15 mg of iron per liter by a new technological procedure in which ferrous sulfate is microencapsulated with phospholipids. Therefore we studied the absorption of this novel iron fortification compound called SFE-171TM by means of the classical double-isotopic method. This study was made in fifteen healthy adult men, none of them were anemic and all of them had normal iron stores. Iron absorption from SFE-171TM in milk was 9.2% when it was standardized to 40% absorption of the reference dose of ferrous ascorbate. We conclude that the iron from ferrous sulfate microencapsulated with phospholipids has a good bioavailability and it is an effective alternative for the fortification of fluid cows milk without affecting its shelf life and its sensorial properties.